Novel Therapies for the Prevention of Fibrosis in Glaucoma Filtration Surgery

Area of Science:

• Ophthalmology
• Biomaterials Science
• Tissue Engineering

Background:

• Conjunctival fibrosis significantly hinders glaucoma filtration surgery outcomes.
• Current anti-metabolite treatments have limitations, including high complication and failure rates.
• Novel therapeutic strategies are needed to prevent scar formation and improve surgical success.

Purpose of the Study:

• To review current and emerging strategies for mitigating conjunctival fibrosis in glaucoma surgery.
• To highlight advancements in understanding molecular and biomechanical factors influencing fibrosis.
• To explore novel therapies and biomaterials for preventing fibrotic scarring.

Main Methods:

• Literature review of scientific publications on conjunctival fibrosis and glaucoma surgery.
• Analysis of molecular signaling pathways involved in tissue remodeling.
• Evaluation of biomaterials and therapeutic approaches for fibrosis mitigation.

Main Results:

• Anti-metabolites are the current standard but have significant drawbacks.
• Emerging strategies focus on targeted molecular and biomechanical interventions.
• New therapies and biomaterials show promise in preclinical and early clinical studies.

Conclusions:

• Developing targeted approaches to conjunctival fibrosis is crucial for advancing glaucoma surgery.
• Further research into molecular signaling and biomechanical cues will drive innovation.
• Novel strategies hold the potential to revolutionize glaucoma treatment and reduce vision loss.